Back to Search
Start Over
Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value.
- Source :
-
Cancer [Cancer] 2002 Apr 15; Vol. 94 (8), pp. 2151-9. - Publication Year :
- 2002
-
Abstract
- Background: Cell proliferation is a major determinant of the biologic behavior of breast carcinoma. MIB-1 monoclonal antibody is a promising tool for determining cell proliferation on routine histologic material. The objectives of this study were to compare MIB-1 evaluation to other methods of measuring cell proliferation, with a view to refining the cutoff used to classify tumors with low and high proliferation rates in therapeutic trials.<br />Methods: One hundred eighty-five invasive breast carcinomas were evaluated for cell proliferation by determining monoclonal antibody MIB-1 staining, histologic parameters (Scarff-Bloom-Richardson grade and mitotic index) on paraffin sections, S-phase fraction (SPF) by flow cytometry, and thymidine-kinase (TK) content of frozen samples.<br />Results: There was a high correlation (P = 0.0001) between the percentage of MIB-1 positive tumor cells and SPF, TK, histologic grade, and the mitotic index. Multivariate analyses including MIB-1 at 5 different cutoffs (10%, 15%, 17% [median], 20%, 25%) and the other proliferative markers showed that the optimal MIB-1 cutoff was 25% and that the mitotic index was the proliferative variable that best discriminated between low and high MIB-1 samples. A MIB-1 cutoff of 25% adequately identified highly proliferative tumors. Conversely, with a MIB-1 cutoff of 10%, few tumors with low proliferation were misclassified.<br />Conclusions: The choice of MIB-1 cutoff depends on the following clinical objective: if MIB-1 is used to exclude patients with slowly proliferating tumors from chemotherapeutic protocols, a cutoff of 10% will help to avoid overtreatment. In contrast, if MIB-1 is used to identify patients sensitive to chemotherapy protocols, it is preferable to set the cutoff at 25%. The MIB-1 index should be combined with some other routinely used proliferative markers, such as the mitotic index.<br /> (Copyright 2002 American Cancer Society.)
- Subjects :
- Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal
Antigens, Nuclear
Biopsy
Breast Neoplasms metabolism
Carcinoma, Ductal, Breast metabolism
Carcinoma, Lobular metabolism
Cell Division
DNA, Neoplasm metabolism
Female
Flow Cytometry
Humans
Immunoenzyme Techniques
Ki-67 Antigen
Middle Aged
Mitotic Index
Neoplasm Invasiveness
Neoplasm Staging
Predictive Value of Tests
Receptors, Estrogen metabolism
Receptors, Progesterone metabolism
Thymidine Kinase metabolism
Biomarkers, Tumor metabolism
Breast Neoplasms pathology
Carcinoma, Ductal, Breast pathology
Carcinoma, Lobular pathology
Nuclear Proteins metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 0008-543X
- Volume :
- 94
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- Cancer
- Publication Type :
- Academic Journal
- Accession number :
- 12001111
- Full Text :
- https://doi.org/10.1002/cncr.10458